Discover and read the best of Twitter Threads about #CholesterolScience
Most recents (3)
1/ Hi all -- I've requested, and @TuckerGoodrich had generously agreed to a re-interview.
We'll record today and I'll have it up soon after.
We'll record today and I'll have it up soon after.
2/ While the original was more debate-like in its format, many pointed to my being unusually interruptive, impatient, and didn't allow completion his analysis at one point.
I was surprised to read these comments at first and rewatched much of the video. The comments were right!
I was surprised to read these comments at first and rewatched much of the video. The comments were right!
3/ I've certainly had many debate/discussions, such as those with the #CholesterolScience series. And while there can be interruptions, talking over each other, etc -- I think (or at least I hope) I manage to maintain graciousness and professionalism as much as possible.
1/ I’d like to address @JTMarlin77’s point in depth...
For what it’s worth, I think it’s not only fair to critize my work, it’s something I invite. Let’s debate the theories, methodologies, and data...
For what it’s worth, I think it’s not only fair to critize my work, it’s something I invite. Let’s debate the theories, methodologies, and data...
2/ In fact, I proactively seek out educated, thoughtful opinions that oppose my hypotheses. I don’t just retweet these individuals, I invite them onto the channel (#CholesterolScience series) and even have amazing people like @DrNadolsky write us a pro LDL lowing case for CC.
3/ I bring this up because — like these same people — I often point to associations out loud all the time.
An example would be the thread @JTMarlin77 was referring to where I pointed out my surprising reduction in symptomatic bacterial / viral sickness since my LDL increased.
An example would be the thread @JTMarlin77 was referring to where I pointed out my surprising reduction in symptomatic bacterial / viral sickness since my LDL increased.
1/ I keep thinking about one exchange @ethanjweiss and I had on the #CholesterolScience broadcast... more so than any I've had in any prior interview before. I've cued it to the right timecode here:
2/ In this moment, we're talking about the finding of the 4S trial that @erreyedoc was mentioning (linked here). And in particular, we're talking about those with high LDL, high HDL, and low TG in the existing statin trial data would show a low risk group.
3/ I point out why I'm genuinely stunned this "positive" triad (and certainly one I'm focused on) hasn't garnered the attention of the medical community. Why wasn't there a push right there to better identify and understand if this specific group was being served by Rx treatment?
